Microvascular resistance of the culprit coronary artery in acute ST-elevation myocardial infarction

JCI Insight

Volumn 1, Issue 6, 2016, Pages

  Carrick, David ^a,b   Haig, Caroline ^c   Carberry, Jaclyn ^a,b   May, Vannesa Teng Yue ^a,b   McCartney, Peter ^a,b   Welsh, Paul ^a   Ahmed, Nadeem ^a   McEntegart, Margaret ^b   Petrie, Mark C ^a,b   Eteiba, Hany ^b   Lindsay, Mitchell ^b   Hood, Stuart ^b   Watkins, Stuart ^b   Mahrous, Ahmed ^b   Rauhalammi, Samuli M O ^b   Mordi, Ify ^a   Ford, Ian ^c   Radjenovic, Aleksandra ^a   Sattar, Naveed ^a   Oldroyd, Keith G ^b   Berry, Colin ^a,b   more..

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b GOLDEN JUBILEE NATIONAL HOSPITAL   (United Kingdom)

^c UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85055599358     PISSN: None     EISSN: 23793708     Source Type: Journal    
DOI: 10.1172/jci.insight.85768     Document Type: Article

References (52)

1. O'Gara PT, et al. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2013; 127(4):e362-e425.
2. Mozaffarian D, et al. Heart disease and stroke statistics - 2015 update: a report from the American Heart Association. Circulation. 2015; 131(4):e29-322.
3. Levine GN, et al. 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. J Am Coll Cardiol. 2011; 58(24):e44-122.
4. British Cardiovascular Intervention Society Audit for Adult Cardiovascular Interventions. BCIS Web site. http://www.bcis.org. uk/documents/39F_BCIS_Audit_2014_23022016_for_web.pdf. Accessed April 8, 2016.
5. Carrick D, et al. Prognostic significance of infarct core pathology revealed by quantitative non-contrast in comparison with contrast cardiac magnetic resonance imaging in reperfused ST-elevation myocardial infarction survivors. Eur Heart J. 2016; 37(13):1044-1059.
6. Robbers LF, et al. Magnetic resonance imaging-defined areas of microvascular obstruction after acute myocardial infarction represent microvascular destruction and haemorrhage. Eur Heart J. 2013; 34(30):2346-2353.
7. Ahmed N, Carrick D, Layland J, Oldroyd KG, Berry C. The role of cardiac magnetic resonance imaging (MRI) in acute myocardial infarction (AMI). Heart Lung Circ. 2013; 22(4):243-255.
8. Carrick D, Berry C. Prognostic importance of myocardial infarct characteristics. Eur Heart J Cardiovasc Imaging. 2013; 14(4):313-315.
9. Frohlich GM, Meier P, White SK, Yellon DM, Hausenloy DJ. Myocardial reperfusion injury: looking beyond primary PCI. Eur Heart J. 2013; 34(23):1714-1722.
10. Chen J, Hsieh AF, Dharmarajan K, Masoudi FA, Krumholz HM. National trends in heart failure hospitalization after acute myocardial infarction for Medicare beneficiaries: 1998-2010. Circulation. 2013; 128(24):2577-2584.
11. Ganame J, et al. Impact of myocardial haemorrhage on left ventricular function and remodelling in patients with reperfused acute myocardial infarction. Eur Heart J. 2009; 30(12):1440-1449.
12. Eitel I, et al. Prognostic value and determinants of a hypointense infarct core in T2-weighted cardiac magnetic resonance in acute reperfused ST-elevation-myocardial infarction. Circ Cardiovasc Imaging. 2011; 4(4):354-362.
13. van Kranenburg M, et al. Prognostic value of microvascular obstruction and infarct size, as measured by CMR in STEMI patients. JACC Cardiovasc Imaging. 2014; 7(9):930-939.
14. de Waha S, et al. Impact of early vs. late microvascular obstruction assessed by magnetic resonance imaging on longterm outcome after ST-elevation myocardial infarction: a comparison with traditional prognostic markers. Eur Heart J. 2010; 31(21):2660-2668.
15. van 't Hof AW, Liem A, Suryapranata H, Hoorntje JC, de Boer MJ, Zijlstra F. Angiographic assessment of myocardial reperfusion in patients treated with primary angioplasty for acute myocardial infarction: myocardial blush grade. Zwolle Myocardial Infarction Study Group. Circulation. 1998; 97(23):2302-2306.
16. Gibson CM, et al. Relationship of TIMI myocardial perfusion grade to mortality after administration of thrombolytic drugs. Circulation. 2000; 101(2):125-130.
17. Barbato E, et al. Validation of coronary flow reserve measurements by thermodilution in clinical practice. Eur Heart J. 2004; 25(3):219-223.
18. Gould KL, Hamilton GW, Lipscomb K, Ritchie JL, Kennedy JW. Method for assessing stress-induced regional malperfusion during coronary arteriography. Experimental validation and clinical application. Am J Cardiol. 1974; 34(5):557-564.
19. Fearon WF, et al. Microvascular resistance is not influenced by epicardial coronary artery stenosis severity: experimental validation. Circulation. 2004; 109(19):2269-2272.
20. Ng MK, Yeung AC, Fearon WF. Invasive assessment of the coronary microcirculation: superior reproducibility and less hemodynamic dependence of index of microcirculatory resistance compared with coronary flow reserve. Circulation. 2006; 113(17):2054-2061.
21. Johnson NP, Kirkeeide RL, Gould KL. Coronary anatomy to predict physiology: fundamental limits. Circ Cardiovasc Imaging. 2013; 6(5):817-832.
22. Cuculi F, et al. Impact of microvascular obstruction on the assessment of coronary flow reserve, index of microcirculatory resistance, and fractional flow reserve after ST-segment elevation myocardial infarction. J Am Coll Cardiol. 2014; 64(18):1894-1904.
23. Fearon WF, et al. Prognostic value of the Index of Microcirculatory Resistance measured after primary percutaneous coronary intervention. Circulation. 2013; 127(24):2436-2441.
24. McGeoch R, et al. The index of microcirculatory resistance measured acutely predicts the extent and severity of myocardial infarction in patients with ST-segment elevation myocardial infarction. JACC Cardiovasc Interv. 2010; 3(7):715-722.
25. Neumann FJ, et al. Cardiac release of cytokines and inflammatory responses in acute myocardial infarction. Circulation. 1995; 92(4):748-755.
26. Guillen I, Blanes M, Gomez-Lechon MJ, Castell JV. Cytokine signaling during myocardial infarction: sequential appearance of IL-1 beta and IL-6. Am J Physiol. 1995; 269(2 pt 2):R229-R235.
27. Echavarria-Pinto M, et al. Disturbed coronary hemodynamics in vessels with intermediate stenoses evaluated with fractional flow reserve: a combined analysis of epicardial and microcirculatory involvement in ischemic heart disease. Circulation. 2013; 128(24):2557-2566.
28. Payne AR, et al. Microvascular resistance predicts myocardial salvage and infarct characteristics in ST-elevation myocardial infarction. J Am Heart Assoc. 2012; 1(4):e002246.
29. Sezer M, et al. Concurrent microvascular and infarct remodeling after successful reperfusion of ST-elevation acute myocardial infarction. Circ Cardiovasc Interv. 2010; 3(3):208-215.
30. Ahmed N, et al. Safety of guidewire-based measurement of fractional flow reserve and the index of microvascular resistance using intravenous adenosine in patients with acute or recent myocardial infarction. Int J Cardiol. 2015; 202:305-310.
31. Carrick D, et al. Myocardial hemorrhage after acute reperfused ST-segment-elevation myocardial infarction: relation to microvascular obstruction and prognostic significance. Circ Cardiovasc Imaging. 2016; 9(1):e004148.
32. van de Hoef TP, et al. Physiological basis and long-term clinical outcome of discordance between fractional flow reserve and coronary flow velocity reserve in coronary stenoses of intermediate severity. Circ Cardiovasc Interv. 2014; 7(3):301-311.
33. Fearon WF, et al. Predictive value of the index of microcirculatory resistance in patients with ST-segment elevation myocardial infarction. J Am Coll Cardiol. 2008; 51(5):560-565.
34. Kitabata H, et al. Coronary microvascular resistance index immediately after primary percutaneous coronary intervention as a predictor of the transmural extent of infarction in patients with ST-segment elevation anterior acute myocardial infarction. JACC Cardiovasc Imaging. 2009; 2(3):263-272.
35. Kramer CM, Barkhausen J, Flamm SD, Kim RJ, Nagel E. Standardized cardiovascular magnetic resonance (CMR) protocols 2013 update. J Cardiovasc Magn Reson. 2013; 15:91.
36. Carrick D, et al. Pathophysiology of LV remodeling in survivors of STEMI: inflammation, remote myocardium, and prognosis. JACC Cardiovasc Imaging. 2015; 8(7):779-789.
37. Giri S, et al. T2 quantification for improved detection of myocardial edema. J Cardiovasc Magn Reson. 2009; 11:56.
38. Verhaert D, et al. Direct T2 quantification of myocardial edema in acute ischemic injury. JACC Cardiovasc Imaging. 2011; 4(3):269-278.
39. Kellman P, Arai AE, McVeigh ER, Aletras AH. Phase-sensitive inversion recovery for detecting myocardial infarction using gadolinium-delayed hyperenhancement. Magn Reson Med. 2002; 47(2):372-383.
40. Flett AS, et al. Evaluation of techniques for the quantification of myocardial scar of differing etiology using cardiac magnetic resonance. JACC Cardiovasc Imaging. 2011; 4(2):150-156.
41. Eitel I, et al. Prognostic significance and determinants of myocardial salvage assessed by cardiovascular magnetic resonance in acute reperfused myocardial infarction. J Am Coll Cardiol. 2010; 55(22):2470-2479.
42. Berry C, et al. Magnetic resonance imaging delineates the ischemic area at risk and myocardial salvage in patients with acute myocardial infarction. Circ Cardiovasc Imaging. 2010; 3(5):527-535.
43. Payne AR, et al. Bright-blood T2-weighted MRI has higher diagnostic accuracy than dark-blood short tau inversion recovery MRI for detection of acute myocardial infarction and for assessment of the ischemic area at risk and myocardial salvage. Circ Cardiovasc Imaging. 2011; 4(3):210-219.
44. Francone M, et al. Impact of primary coronary angioplasty delay on myocardial salvage, infarct size, and microvascular damage in patients with ST-segment elevation myocardial infarction: insight from cardiovascular magnetic resonance. J Am Coll Cardiol. 2009; 54(23):2145-2153.
45. Ghugre NR, et al. Quantitative tracking of edema, hemorrhage, and microvascular obstruction in subacute myocardial infarction in a porcine model by MRI. Magn Reson Med. 2011; 66(4):1129-1141.
46. Kandler D, et al. The relation between hypointense core, microvascular obstruction and intramyocardial haemorrhage in acute reperfused myocardial infarction assessed by cardiac magnetic resonance imaging. Eur Radiol. 2014; 24(12):3277-3288.
47. O'Regan DP, Ariff B, Neuwirth C, Tan Y, Durighel G, Cook SA. Assessment of severe reperfusion injury with T2*cardiac MRI in patients with acute myocardial infarction. Heart. 2010; 96(23):1885-1891.
48. Anderson LJ, et al. Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload. Eur Heart J. 2001; 22(23):2171-2179.
49. Steg PG, et al. ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J. 2012; 33(20):2569-2619.
50. Murray ET, et al. Overweight across the life course and adipokines, inflammatory and endothelial markers at age 60-64 years: evidence from the 1946 birth cohort. Int J Obes (Lond). 2015; 39(6):1010-1018.
51. Thygesen K, et al. Third niversal definition of myocardial infarction. Eur Heart J. 2012; 33(20):2551-2567.
52. Hicks KA, et al. 2014 ACC/AHA Key Data Elements and Definitions for Cardiovascular Endpoint Events in Clinical Trials: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Cardiovascular Endpoints Data Standards). J Am Coll Cardiol. 2015; 66(4):403-469.